Windward Bio Group AG has recently disclosed significant stock transactions involving a key stakeholder, Bonita David P, according to a filing with the SEC. This update, filed on November 18, 2026, highlights the ongoing activity within the company and its efforts to engage investors in the competitive biological products sector.
Windward Bio Group AG operates within the biological products industry, specifically classified under SIC code 2836, which focuses on biological products excluding diagnostic substances. The company is publicly traded on the Nasdaq under the ticker symbol WWB.
The filing indicates that Bonita David P, who is both a director and a ten-percent owner of Windward Bio, executed several transactions on November 16, 2026. These transactions included the acquisition of 1,176,471 common shares at a price of $17.00 each, bringing her total ownership to 1,708,103 shares following this transaction. Additionally, she acquired 3,561,936 common shares through the conversion of Series A Preferred Shares, which were automatically converted into common shares prior to the company's initial public offering.
In total, the filing reveals that David's transactions on that day involved the acquisition of 7,097,715 common shares, reflecting a strong commitment to the company's future. The report notes that these securities are held by OrbiMed Private Investments IX, LP, with David being a member of OrbiMed Advisors, which manages the investments.
This update may have implications for various stakeholders, including current investors, potential investors, and competitors in the biological products industry. The significant share acquisitions by a key stakeholder can signal confidence in the company's future direction and performance, which may influence market perceptions.
As for what happens next, the filing does not specify any forthcoming actions or additional filings related to these transactions. Investors and industry analysts will likely be watching closely for any further developments from Windward Bio Group AG.
Read Next
Benchmark 2026-V25 Mortgage Trust Announces Major Underwriting Deal
ChronoScale Holdings completes $153 million stock purchase deal
Windward Bio Group AG Reports Major Stock Transactions
ClearPoint Neuro amends equity offering to raise $150 million
Ares Core Infrastructure Fund Raises $662.4 Million in Shares
North Haven Net REIT Reports Sale of 234,604 Class I Shares










